A systematic review of non-standard dosing of oral anticancer therapies

BACKGROUND: The use of oral systemic anticancer therapies (SACT) has increased and led to improved cancer survival outcomes, particularly with the introduction of small molecule targeted agents and immunomodulators. Oral targeted SACT are, however, associated with toxicities, which might result in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Djebbari, Faouzi, Stoner, Nicola, Lavender, Verna Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249819/
https://www.ncbi.nlm.nih.gov/pubmed/30466406
http://dx.doi.org/10.1186/s12885-018-5066-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249819/
https://www.ncbi.nlm.nih.gov/pubmed/30466406
http://dx.doi.org/10.1186/s12885-018-5066-2

Ejemplares similares